Lexaria Bioscience Corp.
LEXX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001348362
No open-market purchases or sales by Lexaria Bioscience Corp. insiders were filed in the last 90 days; 31 institutions reported holding it in 13F filings for Q2 2026, worth $920.0K in total; no superinvestor holds it.
Q3 2021 vs. Q2 2021
How the institutions holding Lexaria Bioscience Corp. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Q3 2021 | Change |
|---|---|---|---|
| Holders | 10 | 11 | +1 |
| Shares | 417.4K | 452.0K | +34.6K (+8.3%) |
| Value | $2.93M | $2.83M | −$97.0K (−3.3%) |
New holders (3)
Institutions that held Lexaria Bioscience Corp. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Virtu Financial LLC | 11,941 | $75.0K | 0.01% |
| Morgan Stanley | 1,000 | $6.00K | 0.00% |
| Gables Capital Management Inc. | 13 | $0 | 0.00% |
Sold out (2)
Institutions that held Lexaria Bioscience Corp. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Renaissance Technologies LLC | 17,200 | $120.0K |
| Tower Research Capital LLC (TRC) | 251 | $2.00K |